AMPEL BioSolutions, LLC

http://www.ampelbiosolutions.com
Contract Research Organization | Foundation/Academic | Pharma/Therapeutics/Vaccines | Research/Bioinformatics
Contract Research Organization, Foundation/Academic, Pharma/Therapeutics/Vaccines, Research/Bioinformatics
  • Founded: 2013
  • CEO: Dr. Peter Lipsky
  • Size of Facility: 2500 sq ft
  • Company Size: 10
  • Funding Source: Grants (e.g. SBIR, CRCF, CIT), Privately Held
  • Development Stage: Phase 1-2 Clinical Trials, Pre-clinical

AMPEL  BioSolutions is the leading biomedical research think tank that  creatively addresses clinical development bottlenecks and R&D  roadblocks. AMPEL interrogates, analyzes, synthesizes & interprets  the world’s biomedical knowledge to provide novel solutions for clinical  research questions. Resourceful and dedicated, AMPEL is composed of  leading experts in autoimmunity, immunogenicity, inflammation and  clinical immunology with extensive research and medical experience to  address and resolve obstacles. AMPEL assists nonprofit organizations,  pharmaceutical companies, clinical research groups, and others in basic  research, translational medicine, preclinical research, drug development  and repositioning, and biomarker identification.